Szemészet, 2016 (153. évfolyam, 1-4. szám)

2016-06-01 / 2. szám

Indications and contraindications, surgical methods

117. Roper-Hall MJ. Magnetic Orbital Implant. Br J Ophthalmol 1956; 40: 575.

118. Rubin PA, Popham JK, Bilyk JR, Shore JW. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophtal Plast Reconstr Surg 1994; 10: 96-103.

119. Rubin PAD, Fay AM, Remulla HD. Primary Placement of a Motility Coupling Post in Porous polyethylene Orbital Implants. Arch Ophthalmol 2000; 118: 826-832.

120. Saeed MU, Chang BYR Anand S, Chakrabarty A. Diagnostic Surprise in an Evisceration Specimen Orbit 2007; 26: 129-131.

121. Sagoo MS, Olver JM. Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure. Br J Ophthalmol 2004; 88: 942-946.

122. Sagoo MS, Rose GE. Mechanism and Treatment of Extruding Intraconal Implants Socket Aging and Tissue Restitution (the Cactus Syndrome). Arch Ophthalmol 2007; 123: 1616-1620.

123. Sami D, Young S, Petersen R. Perspective on Orbital Enucleation Implants. Surv Ophthalmol 2007; 52: 244-265.

124. Sarnat BG, Shanedling PD. Orbital Volume following Evisceration, enucleation, and exenteration in rabbits. Am J Ophthalmol 1970; 70: 787-799.

125. Sekundo W, Seifert P Hydroxyapathite Orbital Implant A Light- and Electron-microscopic and Immunhistochemical Study. Ophthalmology 1998; 105: 539-543.

126. Shah-Desai SD, Tyers AG, Manners RM. Painful blind eye: efficacy of enucleation and evisceration in resolving ocular pain. Br J Ophthalmol 2000; 84: 437-438.

127. Shields Cl, Shields JA, Eagle RC, De potter R Histopathologic Evidence of Fibrrovascular Ingrowth Four Weeks After Placement of the Hydroxyatatite Orbital Implant. Am J Ophthalmol 1991; 111: 363-366.

128. Shields CL, Shields JA, De Potter P Hydroxyapatite Orbital Implant After Enucleation. Arch Ophthalmol 1992; 110: 333-338.

129. Shields CL, Shields JA, De Porter R Singh AD. Problems with the hydroxyapazite orbital implant: experience with 250 consecutive cases. BrJ Ophthalmol 1994; 78: 702-706.

130. Shoamanesh A, Pang NK, Oestreicher JH. Complications of Orbital Implants: A Review of 542 Patients Who have Undergone Orbital Implantation and 275 Subsequent Peg Placements. Orbit 2007; 26: 173-182.

131. Sigurdsson H, Thórisdóttir S, Björnsson JK. Enucleation and evisceration in Iceland 1964-1992. Study in a defined population. Acta Ophthalmol Scand 1998; 76: 103-107.

132. Smith B, Petrelli R. Dermis-fat graft as a movable implant within the muscle cone. Am J Ophthalmol 1978; 85: 62-66.

133. Soares EJC, Franca VR Wykrota L, Stumpf S. Clinical evaluation of a new Bioceramic ophthalmic implant Orbit 1995; 14(3): 137-146.

134. Soll DB. Insertion os Sedondary Intraorbital Implants. Arch Ophthalmol 1973; 89: 214-216.

135. Soparkar CNS, Wong JE Patrinely JR, Davidson JK, Appling D. Porous Polyethylene Implant Fibrovascularization Rate Is Affected by Tissue Wrapping, Agrose Coating, and Insertion Site. Ophthall Plast Reconstr Surg 2000; 16: 330-336.

136. Soparkar CNS, Wong JE Patrinely JR., Appling D. Epidermal and Fibroblast Growth factors Enhance Fibrovascular Integration of Porous Polyethylene Implants.Ophthal Plast Reconstr Surg 2000; 16: 337-340.

137. Soparkar CNS, Wong JE Patrinely JR, Appling D. Growth Factors Embedded in an Agarose Matrix Enhance the rate of Porous Polyethylene Implant Biointegration. Ophthal Plast Reconstr Surg 2000; 16: 341-346.

138. Spirnak JR Nieves N, Hollsten DA, White W, Betz ТА. Gadoliniumenhanced Magnetic Resonance Imaging Assessment of Hydroxyapatite Orbital Implants. Am J Ophthalmol 1995; 119: 431-440.

139. Stewart WB, Gratiot JB, Soll DB. Surgical Management of Orbital Implant Extrusion by Implant Placement Posterior to Tenon,s Fascia. Ophtal Surg 1982; 13: 807-811.

140. Su GW, Yen MT. Current Trend sin Managing the Anophthalmic Socket After Primary Enucleation and Evisceration. Ophthal Plast Reconstr Surg 2004 4: 274-280.

141. Suter AJ, Molteno AC, Bevin TH, Fulton JD, Herbison R Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol 2002; 86: 1287-92.

142. Szabó Z. Tapasztalataink perionrost implantátummal. Szemészet 1975; 31:218-222.

143. Thakker MM, Fay AM, Pieroth L, Rubin PAD. Fibrovascular Ingrowth Into Hydroxyapathite and Porous Polyethylene Orbital Implnats Wrapped With Acellular Dermis. Ophthal Plast Reconstr Surg 2004; 20: 368-373.

144. Toft PB, Rasmussen MLR, Prause JU. One-stage explant-implant procedure of exposed porous orbital implants. Acta Ophthalmol 2010; 12: 1-5.

145. Trichopoulos N, Ausburger JJ. Enucleation With Unwrapped Porous and nonporous Orbital Implants: A 15-Year Experience. Ophthal Plast Reconstr Surg 2005; 21: 331-336.

146. Tyers AG, Collin JR. Baseball orbital implants: a review of 39 patients. BrJ Ophtalmol 1985; 69: 438-442.

147. Viswanathan R Sagoo MS, Olver JM. UK national survey of enucleation, evisceration and orbital implant trends. Br J Ophthalmol 2007; 91: 616-619.

148. Wang JK, Liao SL, Lai PC, Lin LLK. Prevention of Exposure of Porous Orbital Implants Following Enucleation. Am J Ophthalmol 2007; 143: 61-67.

149. Wang JK, Liao SL, Lin LLK, Kao SCS, Tseng HS. Porous Orbital Implants, Wraps, and Peg Placement int he Pediatric Population After Enucleation. Am J Ophthalmol 2007; 144: 109-116.

150. Wiggs EO, Becker BB. Extrusion of Enucleation Implants: Treatment With Secondary Implants and Autogenous Temporalis Fascia os Fascia Lata Patch Grafts. Ophthal Surg 1992; 23: 472-476.

151. Yen MT, Anderson RL. Capsular Calcification of Alloplastic Orbital Implants Am J Ophthalmol 2002; 133(2): 289-290.

152. Yoon JS, Lew H, Kim SJ, Lee SY. Exposure Rate of Hydroxiapatite Orbital Implants A 15 - year Experience of 802 Cases. Ophthalmology 2008; 115: 566-572.

153. Zuercher D, Malet T. Mycobacterium Abscessus Infection in a Case of Recurrent Orbital Implant Exposure. Orbit 2007; 26: 337-339.

Levelezési cím

Dn Lukáts Dlga, e-mail: lukatsolga@gmail.com